MARTINELLI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 3.003
EU - Europa 1.486
AS - Asia 325
OC - Oceania 10
SA - Sud America 8
AF - Africa 1
Totale 4.833
Nazione #
US - Stati Uniti d'America 2.990
GB - Regno Unito 612
IT - Italia 304
DE - Germania 159
SE - Svezia 153
CN - Cina 121
HK - Hong Kong 69
UA - Ucraina 69
SG - Singapore 50
TR - Turchia 44
FI - Finlandia 42
FR - Francia 28
BG - Bulgaria 27
IE - Irlanda 19
RU - Federazione Russa 18
BE - Belgio 16
CZ - Repubblica Ceca 14
VN - Vietnam 13
ID - Indonesia 12
AU - Australia 10
CA - Canada 9
RO - Romania 7
NL - Olanda 6
ES - Italia 5
IN - India 5
JP - Giappone 5
AR - Argentina 4
BZ - Belize 4
BR - Brasile 3
MY - Malesia 3
DK - Danimarca 2
HR - Croazia 2
AM - Armenia 1
AT - Austria 1
CL - Cile 1
DZ - Algeria 1
IR - Iran 1
LT - Lituania 1
MK - Macedonia 1
PK - Pakistan 1
Totale 4.833
Città #
Southend 522
Fairfield 475
Woodbridge 288
Ashburn 252
Houston 238
Chandler 236
Seattle 192
Ann Arbor 176
Cambridge 172
Wilmington 146
Nyköping 123
Dearborn 122
Jacksonville 119
Modena 85
Hong Kong 69
Fremont 40
New York 40
Beijing 33
Izmir 29
Princeton 28
Sofia 27
Eugene 26
Bremen 25
San Diego 25
Milan 21
Singapore 21
Helsinki 20
Dublin 19
Rome 17
Brussels 16
Bologna 14
Dong Ket 12
London 12
San Jose 12
Brno 11
Jakarta 11
Redwood City 9
Boardman 8
Des Moines 8
Bari 7
Hefei 7
Munich 7
Phoenix 7
Shanghai 7
Castelnuovo Rangone 6
Falls Church 6
Perugia 5
San Giuliano Milanese 5
Atlanta 4
Belize City 4
Chicago 4
Frankfurt am Main 4
Jinan 4
Kunming 4
Naples 4
Reggio Emilia 4
Saint Petersburg 4
Toronto 4
Verona 4
Amsterdam 3
Barcelona 3
Buenos Aires 3
Civitanova Marche 3
Dongguan 3
Guangzhou 3
Kilburn 3
Los Angeles 3
Norwalk 3
Parma 3
Perth 3
Shenyang 3
Sydney 3
São Paulo 3
Wandsworth 3
Albuquerque 2
Ancona 2
Brighton 2
Brisbane 2
Cava de' Tirreni 2
Changsha 2
Chiswick 2
Clearwater 2
Constanta 2
Dallas 2
Due Carrare 2
Fasano 2
Freiburg 2
Fukushima 2
Fuzhou 2
Gelsenkirchen 2
Genoa 2
Guanzate 2
Indiana 2
Jiaxing 2
Jinhua 2
Lappeenranta 2
Las Vegas 2
Latina 2
Martina Franca 2
Montréal 2
Totale 3.897
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 401
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 278
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 256
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 241
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 223
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 209
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 206
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 200
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 187
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 187
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 184
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 183
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 182
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 181
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 173
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 168
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 167
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 166
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 166
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 165
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 163
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 152
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 129
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 129
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 109
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 80
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 17
Totale 4.902
Categoria #
all - tutte 16.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.726


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.115 77 41 25 64 114 171 204 142 105 54 76 42
2020/2021990 83 52 75 119 180 76 79 84 45 87 51 59
2021/2022572 44 68 51 25 6 56 23 25 55 45 119 55
2022/2023708 72 90 55 64 94 95 8 80 81 5 28 36
2023/2024488 17 22 28 54 74 46 51 64 14 24 43 51
2024/202536 36 0 0 0 0 0 0 0 0 0 0 0
Totale 4.902